| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 1335 | 2020 |
| Human circulating PD-1+ CXCR3− CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses M Locci, C Havenar-Daughton, E Landais, J Wu, MA Kroenke, ... Immunity 39 (4), 758-769, 2013 | 864 | 2013 |
| Structural basis of a shared antibody response to SARS-CoV-2 M Yuan, H Liu, NC Wu, CCD Lee, X Zhu, F Zhao, D Huang, W Yu, Y Hua, ... Science 369 (6507), 1119-1123, 2020 | 528 | 2020 |
| CXCL13 is a plasma biomarker of germinal center activity C Havenar-Daughton, M Lindqvist, A Heit, JE Wu, SM Reiss, K Kendric, ... Proceedings of the National Academy of Sciences 113 (10), 2702-2707, 2016 | 311 | 2016 |
| Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort E Landais, X Huang, C Havenar-Daughton, B Murrell, MA Price, ... PLoS pathogens 12 (1), e1005369, 2016 | 278 | 2016 |
| CD4+ T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines HM Long, TA Haigh, NH Gudgeon, AM Leen, CW Tsang, J Brooks, ... Journal of virology 79 (8), 4896-4907, 2005 | 180 | 2005 |
| A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses JM Steichen, YC Lin, C Havenar-Daughton, S Pecetta, G Ozorowski, ... Science 366 (6470), eaax4380, 2019 | 173 | 2019 |
| An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability MJ Van Gils, TLGM Van Den Kerkhof, G Ozorowski, CA Cottrell, D Sok, ... Nature microbiology 2 (2), 1-10, 2016 | 143 | 2016 |
| Early antibody lineage diversification and independent limb maturation lead to broad HIV-1 neutralization targeting the Env high-mannose patch DT MacLeod, NM Choi, B Briney, F Garces, LS Ver, E Landais, B Murrell, ... Immunity 44 (5), 1215-1226, 2016 | 133 | 2016 |
| The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen C Havenar-Daughton, A Sarkar, DW Kulp, L Toy, X Hu, I Deresa, ... Science translational medicine 10 (448), eaat0381, 2018 | 118 | 2018 |
| Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers E Landais, PL Moore Retrovirology 15, 1-14, 2018 | 105 | 2018 |
| Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding L He, D Sok, P Azadnia, J Hsueh, E Landais, M Simek, WC Koff, ... Scientific reports 4 (1), 6778, 2014 | 105 | 2014 |
| HIV envelope glycoform heterogeneity and localized diversity govern the initiation and maturation of a V2 apex broadly neutralizing antibody lineage E Landais, B Murrell, B Briney, S Murrell, K Rantalainen, ZT Berndsen, ... Immunity 47 (5), 990-1003. e9, 2017 | 93 | 2017 |
| Direct killing of Epstein-Barr virus (EBV)–infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1 E Landais, X Saulquin, E Scotet, L Trautmann, MA Peyrat, JL Yates, ... Blood 103 (4), 1408-1416, 2004 | 87 | 2004 |
| New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation E Landais, PA Romagnoli, AL Corper, J Shires, JD Altman, IA Wilson, ... The Journal of Immunology 183 (12), 7949-7957, 2009 | 77 | 2009 |
| The human T cell immune response to Epstein-Barr virus E Landais, X Saulquin, E Houssaint The International journal of developmental biology 49 (2-3), 285-292, 2005 | 75 | 2005 |
| Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells D Huang, JT Tran, A Olson, T Vollbrecht, M Tenuta, MV Guryleva, ... Nature communications 11 (1), 5850, 2020 | 71 | 2020 |
| Immunogenicity of RNA replicons encoding HIV Env immunogens designed for self-assembly into nanoparticles M Melo, E Porter, Y Zhang, M Silva, N Li, B Dobosh, A Liguori, P Skog, ... Molecular Therapy 27 (12), 2080-2090, 2019 | 69 | 2019 |
| Rapid and focused maturation of a VRC01-class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan J Umotoy, BS Bagaya, C Joyce, T Schiffner, S Menis, KL Saye-Francisco, ... Immunity 51 (1), 141-154. e6, 2019 | 66 | 2019 |
| Scavenger receptors target glycolipids for natural killer T cell activation S Freigang, E Landais, V Zadorozhny, L Kain, K Yoshida, Y Liu, S Deng, ... The Journal of clinical investigation 122 (11), 3943-3954, 2012 | 60 | 2012 |
